The High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran
AbstractThe High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran
Cosman F, de Beur SJ, LeBoff MS et al (2014). Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int, 25:2359-81.
Doosti Irani A, Poorolajal J, Khalilian A et al (2013). Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci, 18:759-66.
El-Hajj Fuleihan G, Adib G, Nauroy L (2011). The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation, Switzerland pp. 102011-105000.
WHO Iran (Islamic Republic of): WHO statistical profile. http://www.who.int/countries/irn/en/
Institute for Health Metrics and Evaluation Iran: How long do people live? http://www.healthdata.org/iran
IRNA Iran’s per capita milk consumption. http://www.irna.ir/en/News/2716240/Social/Iran%E2%80%99s_per_capita_milk_consumption
Hashemipour S, Larijani B, Adibi H et al (2004). Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health, 4:38.
Hovsepian S, Amini M, Aminorroaya A et al (2011). Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr, 29:149-55.
Moussavi M, Heidarpour R, Aminorroaya A et al (2005). Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res, 64:144-8.